SEC Filing Summary: India Globalization Capital, Inc.
Business Context and Reporting Period
This Form 8-K was filed by India Globalization Capital, Inc. (not IGC Pharma, Inc.) on December 28, 2012, reporting events occurring on December 21, 2012. The filing addresses a change in the composition of the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance and does not contain financial statements.
Material Changes
Mr. Ranga Krishna resigned as a director and member of the Audit and Compensation Committees, effective December 31, 2012. The resignation was due to personal reasons and was not the result of any disagreement with the Company regarding operations, policies, or practices. The Board accepted the resignation and invited Mr. Krishna to serve as a senior advisor.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No specific risks or contingencies were disclosed in this report other than the standard disclosure that the resignation was not due to disagreements.
Key Facts for Investor Verification
- Verify the correct registrant name is India Globalization Capital, Inc., not IGC Pharma, Inc.
- Confirm the effective date of Mr. Krishna's resignation is December 31, 2012.
- Note that Mr. Krishna will transition to a senior advisor role rather than leaving the organization entirely.
- Review the attached Press Release (Exhibit 99.1) for additional context on the resignation.